Export of plant extracts continued to rise

Business club, Dec 14 with the continuous growth of the international market demand for green products, the export of traditional Chinese medicine products will continue to increase The dominant products are mainly plant extracts, Chinese herbal pieces and health care products Nowadays, the international economy does not fluctuate greatly, and the trade of traditional Chinese medicine products in China is still growing steadily In 1~9 of 2011, although the world economy recovered, the foundation was still fragile and the risk of global economic downturn increased During this period, China's import and export volume of traditional Chinese medicine products reached US $2.2 billion, up 39% year on year General situation: the import and export of various commodities of traditional Chinese medicine are generally increasing, and extracts are still the main export force From January to September 2011, the export volume of extract was 806 million US dollars, an increase of 46.95% year on year, accounting for 48% of the total export volume of traditional Chinese medicine, and it is still the main export volume of traditional Chinese medicine; the export volume of traditional Chinese medicine was 550 million US dollars, an increase of 30% year on year, accounting for 32.84% of the total export volume of traditional Chinese medicine The biggest increase in the export of health care products is mainly due to the adjustment of statistical codes The export of traditional Chinese medicine is dominated by traditional market, and the overall growth trend is relatively fast Hong Kong, Japan and the United States are still the main export markets of traditional Chinese medicine, with the export volume increasing by more than 41.89% from January to September 2011 China's exports to these three markets account for 43.58% of the total exports of traditional Chinese medicine The structure of export enterprises is diversified, and private enterprises are still the main force of export From January to September 2011, there were 2585 export enterprises of traditional Chinese medicine products, an increase of 87 over the same period of last year, among which 1937 were private enterprises, accounting for 50.86% of the total export amount, an increase of 66.8% over the same period of last year; 29.39% were foreign-funded enterprises; and only 19.67% were state-owned enterprises There are 1155 enterprises engaged in the import of traditional Chinese medicine products, of which 43.59% are foreign-funded enterprises, 38.36% are private enterprises, and only 18.04% are state-owned enterprises A series of national control policies on export characteristics have been gradually effective, and the prices of Chinese herbal medicines have fallen In 2010, the price of Chinese herbal medicines rose sharply, which led to the increase of the export amount of Chinese herbal pieces Influenced by a series of regulatory policies of Chinese medicine industry issued by the state, since August of this year, the market prices of large and medium-sized Chinese medicine that soared in the early stage have declined as a whole, driving the average export prices to a certain extent It is expected that in the future, with a large number of new drugs on the market, the price of traditional Chinese medicine will continue to decline to varying degrees The export of extract continued to rise From January to September 2011, the export of plant extracts continued to maintain the growth trend, and occupied the first place of export commodities of traditional Chinese medicine for many years in a row The international demand for plant extracts is still strong In the third quarter, China's exports of Chinese patent medicine to the European Union fell sharply on a month on month basis On March 31, 2004, the EU issued the directive on the registration procedure of traditional botanical drugs, which stipulates that all botanical drugs sold in the EU market must be registered in accordance with the new regulations before April 30, 2011, and obtain the listing license If there is no registration of traditional medicine, the sale of Chinese patent medicine which is now circulated in the EU market by means of food and health products will be banned The transition period of EU traditional botanical medicine registration directive has passed In the third quarter, China's exports of Chinese patent medicines to EU fell by 24% month on month Although facing the problems of high registration cost, small market scale and sharp decline in exports, some Chinese medicine enterprises have not lost confidence in the EU market, and have begun to carry out relevant registration work in succession In December 2010, the provisions of the Chinese Medicine Ordinance of Hong Kong, China on the registration of Chinese patent medicines came into force, making it more difficult to export Chinese patent medicines In addition to local consumption of traditional Chinese medicine, entrepot trade accounts for a large proportion in Hong Kong every year Nearly 10000 kinds of Chinese patent medicines are sold in Hong Kong, of which more than 7000 are from the mainland From January to September 2011, the export volume of Chinese patent medicines from the mainland to Hong Kong decreased In order to help enterprises cope with the difficulties, during the Canton Fair, the China Chamber of Commerce for the import and export of healthcare products held the "Hong Kong Chinese patent medicine registration conference", which invited the Hong Kong Association of traditional Chinese Medicine Merchants and some Hong Kong Traditional Chinese medicine enterprises to participate The mainland registered enterprises were also very enthusiastic More than 30 representatives from more than 20 enterprises, including Tongrentang, Lanzhou foci and Anhui guangyintang, attended the conference At the meeting, experts from the Hong Kong Association of traditional Chinese medicine merchants were invited to explain the current registration regulations of traditional Chinese medicine in Hong Kong, and to answer the questions raised by mainland enterprises Finally, Hong Kong Traditional Chinese medicine enterprises communicated with mainland enterprises Enterprises have said that in addition to providing enterprises with a more detailed understanding of the details and procedures of the Hong Kong Registration Ordinance for Chinese patent medicines, the symposium has also helped them establish a direct communication bridge with the Hong Kong Association of traditional Chinese Medicine Merchants.